Drug intelligence / Profile preview

arginine veyron

Development stage
Unknown
Lead developer
Pierre Fabre
Modality
Small Molecules
Administration
Oral
01

Overview

Arginine Veyron is an oral pharmaceutical formulation containing L-arginine hydrochloride as its active ingredient. It is primarily indicated for the adjunctive treatment of difficult digestion (dyspepsia), temporary fatigue (functional asthenia), and congenital hyperammonaemia due to urea cycle disorders[3][4][8]. L-arginine is a semiessential amino acid that serves as a precursor to nitric oxide, facilitating vasodilation and playing a key role in protein synthesis, ammonia detoxification via the urea cycle, and energy metabolism[1][5]. In this formulation, it also supports bile production by the liver and its secretion into the intestine[8]. The product is typically administered orally in liquid form.

Brand names
Arginine Veyron
Other names
L-arginine VeyronArginine Veyron oral solution
02

Targets

UCE (Urea cycle enzymes)NOS1 (nNOS)

Beyond the preview

Go deeper on arginine veyron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on arginine veyron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call